Study of Sexuality-Related Characteristics in Young Adults With Schizophrenia Treated With Novel Neuroleptics and in a Comparison Group of Young Adults

Schizophrenia Bulletin

Volumn 29, Issue 3, 2003, Pages 559-572

  Fortier, Pierre ^a   Mottard, Jean Pierre ^a   Trudel, Gilles ^b   Even, Sandrine ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Novel neuroleptics; Schizophrenia; Sexuality

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; EJACULATION; FEMALE; GALACTORRHEA; HUMAN; MAJOR CLINICAL STUDY; MALE; MASTURBATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUALITY;

EID: 0242332617     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a007028     Document Type: Article

References (35)

1. Aizenberg, D.; Zemishlany, Z.; Etrog, P.D.; and Weizman, A. Sexual dysfunction in male schizophrenic patients. Journal of Clinical Psychiatry, 56(7):137-141, 1995.
2. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
3. Andreasen, N.C. Negative symptoms in schizophrenia: Definition and reliability. Archives of General Psychiatry, 39:784-788, 1982.
4. Bhui, K.; Puffet, A.; and Herriot, P. A survey of sexual problems amongst psychiatric inpatients. Social Psychiatry and Psychiatric Epidemiology, 30(2):73-77, 1995.
5. Chouinard, G.; Jones, B.; Remington, G.; Bloom, D.; Addington, D.; MacEwan, W.G.; Labelle, A.; Beauclair, L.; and Arnott, W. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology, 13(1):25-40, 1993.
6. Crawford, A.M.K.; Beasley, C.M.; and Tollefson, G.D. "Impact of an Atypical Antipsychotic Candidate on Prolactin Release." Poster session presented at the Annual Meeting of the American Psychiatric Association, New York, NY, May 1996.
7. Crow, J.T. Molecular pathology of schizophrenia: More than one disease process. British Medical Journal, 12(1):66-68, 1980.
8. Fortier, P. "Questionnaire sur l'Histoire Sexuelle, les Activités Sexuelles, les Dysfonctions Sexuelles et les Troubles du Cycle Menstruel." Unpublished manuscript, 1998.
9. Friedman, S., and Harrison, G. Sexual histories, attitudes and behavior of schizophrenic and normal women. Archives of Sexual Behavior, 13:555-567, 1984.
10. Ghadirian, A.M.; Chouinard, G.; and Annable, L. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. Journal of Nervous and Mental Disease, 170(8):463-467, 1982.
11. Kane, J.M.; Cooper, T.B.; and Sachar, E.J. Clozapine: Plasma level and prolactin responses. Psychopharmacology, 73:184-187, 1981.
12. Kay, S.R.; Opler, L.A.; and Lindenmayer, J.P. Reliability and validity of Positive and Negative Syndrome Scale for schizophrenics. Psychiatry Research, 23:99-110, 1988.
13. Keefe, R.S.; Mohs, R.C.; Losonczy, M.F.; Davidson, M.; Silverman, J.M.; Horvath, T.B.; and Davis, K.L. Premorbid sociosexual functioning and long-term outcome in schizophrenia. American Journal of Psychiatry, 146(2):206-211, 1989.
14. Kleinberg, D.L.; Brecher, M.; and Davis, J.M. "Prolactin Levels and Adverse Events in Patients Treated With Risperidone." Paper presented at the 150th Annual Meeting of the American Psychiatric Association, San Diego, CA, May 1997.
15. Kotin, J.; Wilbert, D.E.; and Verburg, D. Thioridazine and sexual dysfunction. American Journal of Psychiatry, 133:82-85, 1976.
16. Laumann, E.O.; Gagnon, J.H.; Michael, R.T.; and Michaels, S. The Social Organization of Sexuality and Sexual Practices in the United States. Chicago, IL: University of Chicago Press, 1994.
17. Lukoff, D.; Hasick, D.G.; Sullivan, G.; Golden, J.S.; and Nuechterlein, K.H. Sex, education and rehabilitation with schizophrenic male outpatients. Schizophrenia Bulletin, 12(4):669-677, 1986.
18. Lyketsos, G.C.; Sakka, P.; and Maïlis, A. The sexual adjustment of chronic schizophrenics: A preliminary study. British Journal of Psychiatry, 143:376-382, 1983.
19. Marder, S.R. Clinical experience with risperidone. Journal of Clinical Psychiatry, 57(9):57-61, 1996.
20. Marder, S.R., and Meibach, R.C. Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 13:25-40, 1994.
21. McGlashan, T.H., and Bardenstein, K.K. Gender differences in affective, schizoaffective and schizophrenic disorders. Schizophrenia Bulletin, 16(2):319-329, 1990.
22. Mitchell, J.E., and Popkin, M.K. The pathophysiology of sexual dysfunction associated with antipsychotic drug therapy in males: A review. Archives of Sexual Behavior, 12:173-183, 1983.
23. Murray, R.M.; O'Callaghan, E.; Castle, D.J.; and Lewis, S.W. A neurodevelopmental approach to the classification of schizophrenia. Schizophrenia Bulletin, 18(2):319-332, 1992.
24. Raboch, J. The sexual development and life of female schizophrenic patients. Archives of Sexual Behavior, 13(4):341-349, 1984.
25. Riley, A.J. Prolactin and female sexual function. British Journal of Sex Medicine, 11: 14-17, 1984.
26. Snell, E.S.; Fisher, T.D., Jr.; and Andrew, S.W. The Multidimensional Sexuality Questionnaire: An objective self-report measure of psychological tendencies associated with human sexuality. Annals of Sex Research, 6:27-55, 1993.
27. Test, M.A.; Burke, S.S.; and Wallisch, L.S. Gender differences of young adults with schizophrenic disorders in community care. Schizophrenia Bulletin, 16(2):331-344, 1990.
28. Teusch, L.; Scherbaum, N.; Böhme, H.; Bender, S.; Eschmann-Mehl, G. ; and Gastpar, M. Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Pharmacopsychiatry, 28:84-92, 1995.
29. Tollefson, G.D.; Beasley, C.M.; Tran, P.V.; Street, J.S.; Krueger, J.A.; Tamura, R.N.; Graffeo, K.A.; and Thieme, M.E. Olanzapine versus haloperidol in the treatment of schizophrenia, schizoaffective and schizophreniform disorders: Results of an international collaborative trial. American Journal of Psychiatry, 154(4):457-465, 1997.
30. Tran, P.V.; Hamilton, S.H.; Kuntz, A.J.; Potvin, J.H.; Andersen, S.W.; Beasley, C.; and Tollefson, G.D. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. Journal of Clinical Psychopharmacology, 17(5):407-418, 1997.
31. Verhulst, J., and Schneidman, B. Schizophrenia and sexual functioning. Hospital and Community Psychiatry, 32(4):259-262, 1991.
32. Waldinger, M.D. Use of psychoactive agents in the treatment of sexual dysfunction. CNS Drugs, 6(3):204-216, 1996.
33. Wasyluk, J. Psychotropic drugs and sexual dysfunction. Pharmacy News, 11 (4):1-10, 1992.
34. Wein, A.J., and Van Arsdalen, K.N. Drug-induced male dysfunction. Impotence, 15:23-33, 1988.
35. Wyatt, R.J. The dopamine hypothesis: Variations on a theme (II). Psychopharmacology Bulletin, 22:923-927, 1986.